文献速递神经外周血管MR

烟雾病脑小血管病影像标志物与疾病严重程度:基于磁共振成像分析的见解

Cerebral small vessel disease imaging markers and disease severity in moyamoya disease: Insights from magnetic resonance imaging analysis.
PubMed 文献 · Eur J Radiol · 2026-03-25

前瞻性纳入225例烟雾病患者与225例性别年龄匹配健康对照,采用T1WI、T2WI、FLAIR及SWI评估脑小血管病影像标志物。烟雾病患者总CSVD评分及各标志物均显著高于健康对照(P<0.05),年龄、出血、梗死、Suzuki分期≥4及高血小板淋巴细胞比值负担与严重CSVD负担独立相关,疾病严重程度与总CSVD评分的AUC为0.809。

要点

  • 烟雾病患者总CSVD评分及各CSVD影像标志物均显著高于健康对照(P<0.05),无症状患者中亦可见。
  • 年龄、出血、梗死、Suzuki分期≥4及高PLR负担与严重CSVD负担独立相关(校正协变量后)。
  • 疾病严重程度与总CSVD评分的多因素回归模型AUC为0.809。

核心结论

  • 烟雾病患者CSVD影像标志物较健康对照更突出,无症状患者亦然;这些影像指标可反映烟雾病的严重程度与进展状态。

研究设计与样本

  • 前瞻性研究,纳入北京天坛医院2022年7月至2023年12月225例烟雾病患者及225例性别年龄匹配健康对照,采用T1WI、T2WI、FLAIR及SWI序列评估CSVD影像标志物,并行多因素logistic回归分析。

关键影像表现/征象

  • 烟雾病患者总CSVD评分及各CSVD影像标志物水平显著高于健康对照(P<0.05)。
  • 校正协变量后,年龄(OR 1.027 [1.002-1.054];P=0.038)、出血(OR 4.560 [2.063-10.079];P<0.001)、梗死(OR 4.520 [1.899-10.758];P=0.001)、Suzuki分期≥4(OR 3.160 [1.586-6.293];P=0.001)及高血小板淋巴细胞比值负担(OR 2.627 [1.278-5.401];P=0.009)与严重CSVD负担显著相关。
  • 疾病严重程度与总CSVD评分的多因素回归模型AUC为0.809。
  • 疾病严重程度与严重CSVD负担的关联在年龄较高、梗死前分期及缺血表现的患者中更突出。

诊断标准与关键数值

  • 疾病严重程度与总CSVD评分的多因素回归模型AUC=0.809。

临床应用与阅片要点

  • 在烟雾病患者的MRI阅片中应系统评估CSVD影像标志物并计算总CSVD评分,因其可反映疾病严重程度与进展状态。
  • 无症状烟雾病患者亦可出现CSVD影像标志物,阅片时需关注。
  • 年龄较高、梗死前分期及缺血表现的患者中,疾病严重程度与严重CSVD负担的关联更突出。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The clinical significance of the summary cerebral small vessel disease (CSVD) score in moyamoya disease (MMD) was unrecognized. This research sought to investigate the clinical importance of CSVD imaging markers in MMD and assess their potential as markers that reflect the disease severity of MMD.

METHOD: We prospectively included 225 MMD patients at Beijing Tiantan Hospital from July 2022 to December 2023 and 225 gender-age-matched healthy individuals. CSVD imaging markers were assessed using T1-weighted, T2-weighted, fluid-attenuated inversion recovery, and susceptibility-weighted imaging sequences. Multivariable logistic regression analysis was performed to identify factors independently associated with CSVD imaging markers, including cerebrovascular morphology, cerebral hemodynamics, clinical manifestations, and the RNF213 variant.

RESULT: MMD patients showed significantly higher levels of summary CSVD score and each CSVD imaging marker compared with healthy controls (P < 0.05). The age (OR, 1.027 [1.002-1.054]; P = 0.038), hemorrhage (OR, 4.560 [2.063-10.079]; P < 0.001), infarction (OR, 4.520 [1.899-10.758]; P = 0.001), Suzuki stage ≥ 4 (OR, 3.160 [1.586-6.293]; P = 0.001), and high platelet-lymphocyte ratio burden (OR, 2.627 [1.278-5.401]; P = 0.009) were significantly associated with severe CSVD burden after adjusting for covariates. The multivariate regression models demonstrated a significant relationship between the disease severity and summary CSVD score (AUC = 0.809). Furthermore, the associations between disease severity and severe CSVD burden were more prominent among patients with elevated age, preinfarction period stage, and ischemic manifestation.

CONCLUSION: The CSVD imaging markers were more prominent in patients with MMD compared with healthy individuals, even in asymptomatic patients. These imaging indicators can reflect the severity and progression status of MMD.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Sun X, Zeng C, Meng F, et al. Cerebral small vessel disease imaging markers and disease severity in moyamoya disease: Insights from magnetic resonance imaging analysis. Eur J Radiol. 2026. PMID: 41916136. doi:10.1016/j.ejrad.2026.112813

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。